Fischer K - Search Results

1

Pain and functional limitations in patients with severe haemophilia.

van Genderen FR, Fischer K, Heijnen L, de Kleijn P, van den Berg HM, Helders PJ, van Meeteren NL. van Genderen FR, et al. Among authors: fischer k. Haemophilia. 2006 Mar;12(2):147-53. doi: 10.1111/j.1365-2516.2006.01203.x. Haemophilia. 2006. PMID: 16476089

2

The use of the Port-A-Cath in children with haemophilia--a review.

Van Den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. Van Den Berg HM, et al. Among authors: fischer k. Haemophilia. 1998 Jul;4(4):418-20. doi: 10.1046/j.1365-2516.1998.440418.x. Haemophilia. 1998. PMID: 9873764 Review.

3

Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Beek FJ, de Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Thromb Haemost. 2000 Dec;84(6):977-80. Thromb Haemost. 2000. PMID: 11154144

4

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.

van den Berg HM, Fischer K, Mauser-Bunschoten EP, Beek FJ, Roosendaal G, van der Bom JG, Nieuwenhuis HK. van den Berg HM, et al. Among authors: fischer k. Br J Haematol. 2001 Mar;112(3):561-5. doi: 10.1046/j.1365-2141.2001.02580.x. Br J Haematol. 2001. PMID: 11260054 Free article.

5

Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.

Mauser-Bunschoten EP, van der Bom JG, Bongers M, Twijnstra M, Roosendaal G, Fischer K, van den Berg HM. Mauser-Bunschoten EP, et al. Among authors: fischer k. Haemophilia. 2001 Jul;7(4):364-8. doi: 10.1046/j.1365-2516.2001.00513.x. Haemophilia. 2001. PMID: 11442640

6

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2001 Sep;7(5):446-52. doi: 10.1046/j.1365-2516.2001.00545.x. Haemophilia. 2001. PMID: 11554930

7

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

Fischer K, Van Der Bom JG, Prejs R, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, Van Den Berg HM. Fischer K, et al. Haemophilia. 2001 Nov;7(6):544-50. doi: 10.1046/j.1365-2516.2001.00560.x. Haemophilia. 2001. PMID: 11851751

8

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

van den Berg HM, Fischer K, van der Bom JG, Roosendaal G, Mauser-Bunschoten EP. van den Berg HM, et al. Among authors: fischer k. Haemophilia. 2002 Mar;8 Suppl 2:43-6. doi: 10.1046/j.1351-8216.2001.00120.x. Haemophilia. 2002. PMID: 11966853

9

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

Fischer K, van der Bom JG, Molho P, Negrier C, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2002 Nov;8(6):745-52. doi: 10.1046/j.1365-2516.2002.00695.x. Haemophilia. 2002. PMID: 12410642

10

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

Fischer K, Astermark J, van der Bom JG, Ljung R, Berntorp E, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2002 Nov;8(6):753-60. doi: 10.1046/j.1365-2516.2002.00694.x. Haemophilia. 2002. PMID: 12410643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,856 results

Search Page

Filters